Seres Therapeutics Inc. (MCRB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
18.93
0.03 (0.16%)
At close: Sep 26, 2025, 3:59 PM
18.93
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Seres Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.79M 127.97M 163.03M 180M
Short-Term Investments
n/a n/a 18.31M 110.7M
Long-Term Investments
8.67M 9.59M 9.59M 495K
Other Long-Term Assets
31K 41.35M 10.46M 14.59M
Receivables
4.75M 8.67M n/a n/a
Inventory
n/a 29.65M n/a n/a
Other Current Assets
-2.68M 9.12M 13.42M n/a
Total Current Assets
38.67M 175.41M 194.76M 303.63M
Property-Plant & Equipment
92.44M 132.25M 133.97M 36.15M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
101.14M 183.19M 154.02M 51.23M
Total Assets
139.81M 358.6M 348.78M 354.86M
Account Payables
4.08M 3.64M 17.44M 13.73M
Deferred Revenue
n/a 7.73M 4.26M 16.82M
Short-Term Debt
8.67M 5.59M 456K 6.61M
Other Current Liabilities
19.8M 58.56M 34.77M 29.27M
Total Current Liabilities
41.22M 98.66M 85.6M 82.26M
Long-Term Debt
82.97M 101.54M 50.59M 24.64M
Other Long-Term Liabilities
1.84M 16.24M 1.44M 11.49M
Total Long-Term Liabilities
84.8M 304.8M 252.41M 141.09M
Total Liabilities
126.03M 403.46M 338M 223.35M
Total Debt
91.64M 213.94M 162.59M 49.21M
Book Value
13.78M -44.86M 10.78M 131.51M
Book Value Per Share
0.09 -0.35 0.10 28.68
Common Stock
173K 135K 125K 92K
Retained Earnings
-978.1M -978.24M -864.51M -614.35M
Comprehensive Income
n/a n/a -12K -60K
Shareholders Equity
13.78M -44.86M 10.78M 131.51M
Total Investments
8.67M 9.59M 18.31M 111.2M